Skip to content

LENZ THERAPEUTICS, INC.

LENZ

CIK 0001815776

← back to feed
Revenue (TTM)
$19.09M
Q1 May 2026
Net Income (TTM)
−$87.72M
−65.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.97
−21.8% YoY Q1 May 2026
Gross Margin
97.8%
Q1 May 2026
Operating Margin
-507.2%
Q1 May 2026
Net Margin
-459.6%
Q1 May 2026
Free Cash Flow (TTM)
−$86.5M
Q1 May 2026
Cash
$24.77M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
31.35M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings